| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.36 | 0.008 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.42 | 0.009 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |